EXPERIMENTAL EVALUATION OF THE METHODS FOR <i>FRANCISELLA TULARENSIS </i>15 NIIEG BIOMASS CONCENTRATION TO BE USED IN MANUFACTURING OF LIVE TULAREMIA VACCINE

EXPERIMENTAL EVALUATION OF THE METHODS FOR <i>FRANCISELLA TULARENSIS </i>15 NIIEG BIOMASS CONCENTRATION TO BE USED IN MANUFACTURING OF LIVE TULAREMIA VACCINE

The possibility of applying sedimentation, centrifuge, and filtration techniques for concentration of F. tularensis 15 NIIEG suspensions obtained after submerged cultivation has been evaluated. It is established that realization of tangential ultrafiltration as part of technological process of live...

Full description

Bibliographic Details
Main Authors:	D. N. Bibikov, O. A. Volokh, A. V. Komissarov, Yu. I. Samokhvalova, N. G. Avdeeva, A. K. Nikiforov
Format:	Article
Language:	Russian
Published:	LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2019-01-01
Series:	Разработка и регистрация лекарственных средств
Subjects:	концентрирование живая туляремийная вакцина
Online Access:	https://www.pharmjournal.ru/jour/article/view/418

Similar Items

Experimental Technology for O-Antigens Production of Non-Toxigenic Strains of <I>Vibrio cholerae</I>
by: S. A. Eremin, et al.
Published: (2013-03-01)

Immunogenic Properties of Cell Wall Preparations of Francisella tularensis Different Subspecies in Experimental Tularemia
by: A. V. Korneva, et al.
Published: (2018-04-01)

Comprehensive Immunological Study of Persons Vaccinated with Live Plague Vaccine Living on the Territory of the Pre-Caspian Sand Foci of the Plague in the Republic of Kalmykia
by: S. A. Bugorkova, et al.
Published: (2018-06-01)

Activation of T-helper in vitro under the Influence of Yersinia pestis Antigens in People Vaccinated against the Plague
by: V. A. Kozhevnikov, et al.
Published: (2022-11-01)

Prospects for improving evaluation of live tularemia vaccine quality
by: I. V. Kasina, et al.
Published: (2018-02-01)

A Clinical Study of the Safety and Tolerability of Live Nasal Vaccines for the Prevention of Pertussis
by: A. Yu. Medkova, et al.
Published: (2021-02-01)

Pre-Clinical Toxicity Study and Safety Assessment of Candidate Live Pertussis Vaccine for Intranasal Administration
by: L. N. Sinyashina, et al.
Published: (2019-01-01)

Estimation of the Severity of Experimental Tularemia against a Number of Morphometric Characteristics
by: S. A. Bugorkova, et al.
Published: (2013-06-01)

Development of a Method and a Scheme for the Use of a Live Recombinant Vaccine "GamLPV". Safety and Tolerability of Double Intranasal Vaccination of Healthy Adult Volunteers
by: G. I. Karataev, et al.
Published: (2022-09-01)

Deployment of Ultrafiltration for Concentrating and Purification of Antigens
by: A. V. Komissarov, et al.
Published: (2015-03-01)

Information support for monitoring post-vaccination immunity against plague
by: O. M. Kudryavtseva, et al.
Published: (2021-07-01)

Immunogenicity and Protective Effect of Live Cold-Adapted Vaccines against Influenza B after Intranasal Immunization of Mice
by: O. S. Kashirina, et al.
Published: (2015-08-01)

Whole-Genome Sequencing and Phylogenetic Analysis of <i>Francisella tularensis</i> Vaccine Strain 15 NIIEG
by: E. A. Naryshkina, et al.
Published: (2020-07-01)

Characterization of Immunogenic and Protective Properties of the Modified Variants of the Strain Francisella tularensis 15 NIIEG
by: A. S. Kartseva, et al.
Published: (2020-10-01)

Special topic on Francisella tularensis and tularemia
by: Anders eSjostedt
Published: (2011-04-01)

Characteristics of Phenotypic and Genetic Properties of <i>Francisella tularensis</i> 15 NIIEG Vaccine Strain with an Extended Storage Period
by: E. A. Solov’Ev, et al.
Published: (2015-12-01)

Improvement of Approaches to the Verification of the Vaccine Strain <i>Francisella tularensis</i> 15 NIIEG during Long-Term Storage
by: L. V. Sayapina, et al.
Published: (2022-10-01)

Analysis of the Features of the Genomic Organization of Plague Microbe Strains Suitable for the Creation of a New Attenuated Vaccine
by: A. V. Grigorievykh, et al.
Published: (2022-11-01)

The Results of the Mass Immunization Program against Rotavirus Infection of Children of the First year of Life in a Separate Territory of the Moscow Region
by: L. V. Feklisova, et al.
Published: (2019-09-01)

Immunobiological Properties of <i>Francisella tularensis</i> Antigen Complexes
by: E. M. Kuznetsova, et al.
Published: (2011-06-01)

Studies of Immunobiological Properties in <i>Francisella tularensis</i> Vaccine Strain 15 NIIEG under Extended Storage Conditions
by: L. V. Sayapina, et al.
Published: (2015-06-01)

CHARACTERISTICS OF THE PROTECTIVE ANTIGEN COMPLEX OBTAINED FROM FRANCISELLA TULARENSIS SSP. NOVICIDA
by: E. M. Kuznetsova, et al.
Published: (2017-06-01)

<i>Francisella tularensis</i> Subspecies <i>holarctica</i> and Tularemia in Germany
by: Sandra Appelt, et al.
Published: (2020-09-01)

Assessment of Residual Virulence of Francisella tularensis 15 NIIEG Vaccine Strain Based on Long-term Observations
by: L. V. Sayapina, et al.
Published: (2018-04-01)

Preclinical Studies of the Specific Activity of the Live Culture Vaccine VACD6 against Smallpox and other Orthopoxvirus Infections
by: S. N. Shchelkunov, et al.
Published: (2023-01-01)

Development of Immunoassays for Detection of <i>Francisella tularensis</i> Lipopolysaccharide in Tularemia Patient Samples
by: Emily E. Hannah, et al.
Published: (2021-07-01)

Electro-Optical Analysis of Cell Viability of Tularemia Microbe Vaccine Strain
by: O. A. Volokh, et al.
Published: (2020-10-01)

Determinants of resistance of <i>Francisella tularensis</i> to environmental stress
by: S. V. Borisova, et al.
Published: (2022-07-01)

Francisella tularensis Bacteria Associated with Feline Tularemia in the United States
by: Marilynn A. Larson, et al.
Published: (2014-12-01)

Host Immunity and <i>Francisella tularensis</i>: A Review of Tularemia in Immunocompromised Patients
by: Olivier Bahuaud, et al.
Published: (2021-12-01)

Live tularemia vaccine quality assessment according to test results under the mandatory certification
by: I. V. Kasina, et al.
Published: (2018-02-01)

Phylogeography of Francisella tularensis subspecies holarctica and epidemiology of tularemia in Switzerland
by: Sara Doina Schütz, et al.
Published: (2023-04-01)

A General Overview of Francisella tularensis and the Epidemiology of Tularemia in Turkey
by: Selçuk KILIÇ
Published: (2010-06-01)

Development and Properties of <i>Francisella tularensis</i> Subsp. <i>holarctica</i> 15 NIIEG Vaccine Strain without the <i>recD</i> Gene
by: Vitaly Pavlov, et al.
Published: (2022-01-01)

Properties of Experimental and Standard Preparations of the Protective O Antigen of <I>Vibrio cholerae</I> M41 Ogawa
by: Yu. A. Aleshina, et al.
Published: (2013-06-01)

Structural and Functional Characterization of Main <i>Francisella tularensis</i> Antigens
by: E.M. Kuznetchova, et al.
Published: (2009-04-01)

The Biological Properties of the Strain Francisella tularensis 15 NIIEG with Decreased Gene Expression sodB, Encoding Fe-Dependent Superoxide Dismutase
by: M. A. Sotnikova, et al.
Published: (2016-10-01)

Differences in Blood-Derived <i>Francisella tularensis</i> Type B Strains from Clinical Cases of Tularemia
by: Marilynn A. Larson, et al.
Published: (2020-10-01)

Assessment of Diagnostic Efficiency of PCR Kits «Gen Francisella tularensis - REF» and «Gen Francisella tularensis - RGF» when Analyzing Biological Samples from Animals with Experimental Tularemia
by: A. M. Senichkina, et al.
Published: (2016-12-01)

Human Tularemia Epididymo-Orchitis Caused by Francisella tularensis Subspecies holartica, Austria
by: Maximilian Seles, et al.
Published: (2023-10-01)